{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:19Z","timestamp":1793900479110,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC3501200"],"award-info":[{"award-number":["2022YFC3501200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Projects","doi-asserted-by":"crossref","award":["82274080"],"award-info":[{"award-number":["82274080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"School Management Project of Fujian University of Traditional Chinese Medicine","award":["X2024019"],"award-info":[{"award-number":["X2024019"]}]},{"name":"School Management Project of Fujian University of Traditional Chinese Medicine","award":["X2024035"],"award-info":[{"award-number":["X2024035"]}]},{"name":"Fujian Provincial Science and Technology Innovation Joint Fund Project","award":["2024Y9511"],"award-info":[{"award-number":["2024Y9511"]}]},{"name":"the Research Support Program Fellowship, Western Sydney University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Ginsenoside Rd (G-Rd), found in\n                      <jats:italic>Panax<\/jats:italic>\n                      species, has shown therapeutic potential against metabolism-associated fatty liver disease (MAFLD), but its mechanism has not been well elucidated. This study investigated the key mechanisms of G-Rd in modulating the gut microbiome and lipid peroxidation-mediated ferroptosis pathway in MAFLD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A high-fat diet-induced MAFLD model was established. Ultrastructural changes in liver tissue were observed using transmission electron microscopy. Metagenomics were employed to detect alterations in gut microbiota and their metabolites. Biochemical analysis and immunohistochemistry were used to examine liver injury, blood lipids, lipid peroxidation-related indicators, and tissue iron content.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      G-Rd significantly reduced liver injury and steatosis in MAFLD mice and downregulated the elevated relative abundance of\n                      <jats:italic>Firmicutes<\/jats:italic>\n                      and the Firmicutes\/Bacteroidetes ratio. It also significantly reduced the abundances of\n                      <jats:italic>Faecalibaculum rodentium<\/jats:italic>\n                      while increasing\n                      <jats:italic>Muribaculum intestinale<\/jats:italic>\n                      , with its functional role being relevant to lipid metabolism regulation. Moreover, G-Rd ameliorated mitochondrial damage and inhibited the ferroptosis pathway in the liver, which was associated with antioxidant-related factors mediated by Nrf2 signaling. The liver protective effect of G-Rd was driven by the regulation of gut microbiota, as demonstrated by antibiotic cocktail treatment and fecal microbiota transplantation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>G-Rd attenuated HFD-induced MAFLD by alleviating liver oxidative stress, lipid peroxidation, and ferroptosis through modulation of the gut microbiota. The antioxidant and anti-ferroptotic actions of G-Rd, mediated via the Nrf2 pathway, were found to contribute to the amelioration of liver injury and hepatic steatosis in MAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01121-1","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:53:10Z","timestamp":1749527590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenjing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-4499","authenticated-orcid":false,"given":"Yanfang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"79","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;79:851\u201361. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"694","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;694:896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036.","journal-title":"J Hepatol"},{"key":"1121_CR3","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023. https:\/\/doi.org\/10.3350\/cmh.2022.0365.","journal-title":"Clin Mol Hepatol"},{"key":"1121_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32511-3","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3.","journal-title":"Lancet"},{"key":"1121_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014.","journal-title":"Metabolism"},{"key":"1121_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052350","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22052350.","journal-title":"Int J Mol Sci"},{"key":"1121_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/oby.22964","volume":"2810","author":"MP Moore","year":"2020","unstructured":"Moore MP, Cunningham RP, Dashek RJ, Mucinski JM, Rector RS. A Fad too Far? Dietary strategies for the prevention and treatment of NAFLD. Obesity (Silver Spring). 2020;2810:1843\u201352. https:\/\/doi.org\/10.1002\/oby.22964.","journal-title":"Obesity (Silver Spring)"},{"key":"1121_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","volume":"312","author":"EM Brown","year":"2023","unstructured":"Brown EM, Clardy J, Xavier RJ. Gut microbiome lipid metabolism and its impact on host physiology. Cell Host Microbe. 2023;312:173\u201386. https:\/\/doi.org\/10.1016\/j.chom.2023.01.009.","journal-title":"Cell Host Microbe"},{"key":"1121_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba3683","author":"W Yoo","year":"2021","unstructured":"Yoo W, Zieba JK, Foegeding NJ, Torres TP, Shelton CD, Shealy NG, Byndloss AJ, Cevallos SA, Gertz E, Tiffany CR, et al. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science. 2021. https:\/\/doi.org\/10.1126\/science.aba3683.","journal-title":"Science"},{"key":"1121_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1930874","volume":"131","author":"Y Hong","year":"2021","unstructured":"Hong Y, Sheng L, Zhong J, Tao X, Zhu W, Ma J, Yan J, Zhao A, Zheng X, Wu G, et al. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Gut Microbes. 2021;131:1\u201320. https:\/\/doi.org\/10.1080\/19490976.2021.1930874.","journal-title":"Gut Microbes."},{"key":"1121_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"633","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;633:764\u201375. https:\/\/doi.org\/10.1002\/hep.28356.","journal-title":"Hepatology"},{"key":"1121_CR12","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","volume":"9","author":"D Porras","year":"2018","unstructured":"Porras D, Nistal E, Mart\u00ednez-Fl\u00f3rez S, Gonz\u00e1lez-Gallego J, Garc\u00eda-Mediavilla MV, S\u00e1nchez-Campos S. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease. Front Physiol. 2018;9:1813. https:\/\/doi.org\/10.3389\/fphys.2018.01813.","journal-title":"Front Physiol"},{"key":"1121_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","volume":"1587","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Cl\u00e9ment K. Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? Gastroenterology. 2020;1587:1881\u201398. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.049.","journal-title":"Gastroenterology"},{"key":"1121_CR14","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"7518","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;7518:3313\u201327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6.","journal-title":"Cell Mol Life Sci"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"241","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP, Peng XD, Li X, Huang Y, Zhu XY, et al. PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol. 2022;241:88\u201398. https:\/\/doi.org\/10.1038\/s41556-021-00818-3.","journal-title":"Nat Cell Biol"},{"key":"1121_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.freeradbiomed.2020.10.323","volume":"162","author":"S Li","year":"2021","unstructured":"Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435\u201349. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.10.323.","journal-title":"Free Radic Biol Med"},{"key":"1121_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194968","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO. Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20194968.","journal-title":"Int J Mol Sci"},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. https:\/\/doi.org\/10.1155\/2014\/360438.","journal-title":"Oxid Med Cell Longev"},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"272","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, Yang H, Lei L, Guo M, Ding HF, Zhang J, Wang H, Chen X, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death Differ. 2020;272:662\u201375. https:\/\/doi.org\/10.1038\/s41418-019-0380-z.","journal-title":"Cell Death Differ"},{"key":"1121_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"291","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;291:61\u201374. https:\/\/doi.org\/10.1089\/ars.2017.7115.","journal-title":"Antioxid Redox Signal"},{"key":"1121_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417203","author":"T Liu","year":"2023","unstructured":"Liu T, Wu H, Wei J. The construction and validation of a novel ferroptosis-related gene signature in Parkinson\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242417203.","journal-title":"Int J Mol Sci"},{"key":"1121_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111660","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang E, Hu H. Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9111660.","journal-title":"Biomedicines."},{"key":"1121_CR23","doi-asserted-by":"publisher","first-page":"29735","DOI":"10.1021\/acsomega.3c04122","volume":"832","author":"T Cui","year":"2023","unstructured":"Cui T, Xiao X, Pan Z, Tang K, Zhong Y, Chen Y, Guo J, Duan S, Zhong G, Li T, et al. Harnessing the therapeutic potential of ginsenoside Rd for activating SIRT6 in treating a mouse model of nonalcoholic fatty liver disease. ACS Omega. 2023;832:29735\u201345. https:\/\/doi.org\/10.1021\/acsomega.3c04122.","journal-title":"ACS Omega"},{"key":"1121_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1142\/s0192415x23500064","volume":"511","author":"Y Li","year":"2023","unstructured":"Li Y, Yu P, Fu W, Wang S, Zhao W, Ma Y, Wu Y, Cui H, Yu X, Fu L, et al. Ginsenoside Rd inhibited ferroptosis to alleviate CCl(4)-induced acute liver injury in mice via cGAS\/STING pathway. Am J Chin Med. 2023;511:91\u2013105. https:\/\/doi.org\/10.1142\/s0192415x23500064.","journal-title":"Am J Chin Med"},{"key":"1121_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678x2094382","volume":"409","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 2020;409:1769\u201377. https:\/\/doi.org\/10.1177\/0271678x2094382.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1121_CR26","unstructured":"Health N I o. Public Health Service Policy on Humane Care and Use of Laboratory Animals. 1986;"},{"key":"1121_CR27","doi-asserted-by":"publisher","first-page":"110155","DOI":"10.1016\/j.biopha.2020.110155","volume":"127","author":"Z Xie","year":"2020","unstructured":"Xie Z, Gao G, Wang H, Li E, Yuan Y, Xu J, Zhang Z, Wang P, Fu Y, Zeng H, et al. Dehydroabietic acid alleviates high fat diet-induced insulin resistance and hepatic steatosis through dual activation of PPAR-\u03b3 and PPAR-\u03b1. Biomed Pharmacother Biomedecine & pharmacotherapie. 2020;127:110155. https:\/\/doi.org\/10.1016\/j.biopha.2020.110155.","journal-title":"Biomed Pharmacother Biomedecine & pharmacotherapie."},{"key":"1121_CR28","doi-asserted-by":"publisher","first-page":"112697","DOI":"10.1016\/j.celrep.2023.112697","volume":"427","author":"L Li","year":"2023","unstructured":"Li L, Sun H, Chen J, Ding C, Yang X, Han H, Sun Q. Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1\/2-PPAR\u03b3-Cd36 pathway. Cell Rep. 2023;427:112697. https:\/\/doi.org\/10.1016\/j.celrep.2023.112697.","journal-title":"Cell Rep"},{"key":"1121_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/j.gastro.2021.08.041","volume":"1621","author":"J Yang","year":"2022","unstructured":"Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, Coker OO, Lau HCH, Chan AWH, Sung JJY, et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology. 2022;1621:135-149.e132. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.041.","journal-title":"Gastroenterology"},{"key":"1121_CR30","doi-asserted-by":"publisher","first-page":"890444","DOI":"10.3389\/fphar.2022.890444","volume":"13","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Zhou X, Wang C, Zhang J, Chang D, Liu W, Zhu M, Zhuang S, Shi H, Wang X, et al. Effect of tanshinone IIA on gut microbiome in diabetes-induced cognitive impairment. Front Pharmacol. 2022;13:890444. https:\/\/doi.org\/10.3389\/fphar.2022.890444.","journal-title":"Front Pharmacol"},{"key":"1121_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8010","author":"WJ Liu","year":"2023","unstructured":"Liu WJ, Chen WW, Chen JY, Sun YB, Chang D, Wang CX, Xie JD, Lin W, Li SH, Xu W, et al. Baicalin attenuated metabolic dysfunction-associated fatty liver disease by suppressing oxidative stress and inflammation via the p62-Keap1-Nrf2 signalling pathway in db\/db mice. Phytother Res. 2023. https:\/\/doi.org\/10.1002\/ptr.8010.","journal-title":"Phytother Res"},{"key":"1121_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"533","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;533:810\u201320. https:\/\/doi.org\/10.1002\/hep.24127.","journal-title":"Hepatology"},{"key":"1121_CR33","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1039\/d3fo01315d","volume":"1412","author":"L Cui","year":"2023","unstructured":"Cui L, Tan YJ, Xu SQ, Qin BF, Xiu MX, Zhang X, Shi LQ, Sun HM, Song J. Ginsenoside Rd, a natural production for attenuating fibrogenesis and inflammation in hepatic fibrosis by regulating the ERR\u03b1-mediated P2X7r pathway. Food Funct. 2023;1412:5606\u201319. https:\/\/doi.org\/10.1039\/d3fo01315d.","journal-title":"Food Funct"},{"key":"1121_CR34","doi-asserted-by":"publisher","first-page":"115237","DOI":"10.1016\/j.jep.2022.115237","volume":"292","author":"MS Poornima","year":"2022","unstructured":"Poornima MS, Sindhu G, Billu A, Sruthi CR, Nisha P, Gogoi P, Baishya G. Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1\/p-LKB-1\/AMPK, HMGCR & PPAR-\u03b1 signaling pathways. J Ethnopharmacol. 2022;292:115237. https:\/\/doi.org\/10.1016\/j.jep.2022.115237.","journal-title":"J Ethnopharmacol"},{"key":"1121_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40360-023-00730-6","volume":"251","author":"X Wang","year":"2024","unstructured":"Wang X, Wang J, Ying C, Xing Y, Su X, Men K. Fenofibrate alleviates NAFLD by enhancing the PPAR\u03b1\/PGC-1\u03b1 signaling pathway coupling mitochondrial function. BMC Pharmacol Toxicol. 2024;251:7. https:\/\/doi.org\/10.1186\/s40360-023-00730-6.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1121_CR36","doi-asserted-by":"publisher","first-page":"154798","DOI":"10.1016\/j.metabol.2021.154798","volume":"120","author":"J Yoo","year":"2021","unstructured":"Yoo J, Jeong IK, Ahn KJ, Chung HY, Hwang YC. Fenofibrate, a PPAR\u03b1 agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy. Metabolism. 2021;120:154798. https:\/\/doi.org\/10.1016\/j.metabol.2021.154798.","journal-title":"Metabolism"},{"key":"1121_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2710.2009.01029.x","volume":"345","author":"D Hajdu","year":"2009","unstructured":"Hajdu D, Aiglov\u00e1 K, Vinklerov\u00e1 I, Urb\u00e1nek K. Acute cholestatic hepatitis induced by fenofibrate. J Clin Pharm Ther. 2009;345:599\u2013602. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01029.x.","journal-title":"J Clin Pharm Ther"},{"key":"1121_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2131\/jts.34.377","volume":"344","author":"A Kobayashi","year":"2009","unstructured":"Kobayashi A, Suzuki Y, Kuno H, Sugai S, Sakakibara H, Shimoi K. Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats. J Toxicol Sci. 2009;344:377\u201387. https:\/\/doi.org\/10.2131\/jts.34.377.","journal-title":"J Toxicol Sci"},{"key":"1121_CR39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/jamasurg.2013.5","volume":"1486","author":"TE Sweeney","year":"2013","unstructured":"Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg. 2013;1486:563\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2013.5.","journal-title":"JAMA Surg"},{"key":"1121_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"191","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;191:55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9.","journal-title":"Nat Rev Microbiol"},{"key":"1121_CR41","doi-asserted-by":"publisher","first-page":"911250","DOI":"10.3389\/fphar.2022.911250","volume":"13","author":"XF Chen","year":"2022","unstructured":"Chen XF, Wang Y, Ji S, Sun X, Feng Q, Yu H, Liu C. Hepatoprotective efficacy and interventional mechanism of Qijia Rougan decoction in liver fibrosis. Front Pharmacol. 2022;13:911250. https:\/\/doi.org\/10.3389\/fphar.2022.911250.","journal-title":"Front Pharmacol"},{"key":"1121_CR42","doi-asserted-by":"publisher","first-page":"1169843","DOI":"10.3389\/fnut.2023.1169843","volume":"10","author":"Z Yanan","year":"2023","unstructured":"Yanan Z, Lu M, Lu Z, Jinhai H, Weiming W. Effects and action mechanisms of lotus leaf (Nelumbo nucifera) ethanol extract on gut microbes and obesity in high-fat diet-fed rats. Front Nutr. 2023;10:1169843. https:\/\/doi.org\/10.3389\/fnut.2023.1169843.","journal-title":"Front Nutr"},{"key":"1121_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jff.2023.105968","volume":"112","author":"LY Shang","year":"2024","unstructured":"Shang LY, Zhang S, Zhang M, Sun XD, Wang Q, Liu YJ, Zhao YN, Zhao M, Wang PJ, Gao XL. Natto alleviates hyperlipidemia in high-fat diet-fed mice by modulating the composition and metabolic function of gut microbiota. J Funct Foods. 2024;112:1\u201313. https:\/\/doi.org\/10.1016\/j.jff.2023.105968.","journal-title":"J Funct Foods"},{"key":"1121_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.reth.2024.03.024","volume":"27","author":"M Liu","year":"2024","unstructured":"Liu M, Du X, Chen H, Bai C, Lan L. Systemic investigation of di-isobutyl phthalate (DIBP) exposure in the risk of cardiovascular via influencing the gut microbiota arachidonic acid metabolism in obese mice model. Regen Ther. 2024;27:290\u2013300. https:\/\/doi.org\/10.1016\/j.reth.2024.03.024.","journal-title":"Regen Ther."},{"key":"1121_CR45","doi-asserted-by":"publisher","first-page":"153354","DOI":"10.1016\/j.phymed.2020.153354","volume":"79","author":"JE Lee","year":"2020","unstructured":"Lee JE, Lee SM, Jung J. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse. Phytomedicine. 2020;79:153354. https:\/\/doi.org\/10.1016\/j.phymed.2020.153354.","journal-title":"Phytomedicine"},{"key":"1121_CR46","doi-asserted-by":"publisher","first-page":"893561","DOI":"10.3389\/fphar.2022.893561","volume":"13","author":"X Luo","year":"2022","unstructured":"Luo X, Zhang B, Pan Y, Gu J, Tan R, Gong P. Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology. Front Pharmacol. 2022;13:893561. https:\/\/doi.org\/10.3389\/fphar.2022.893561.","journal-title":"Front Pharmacol"},{"key":"1121_CR47","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1016\/j.cell.2022.08.005","volume":"18519","author":"Y Kawano","year":"2022","unstructured":"Kawano Y, Edwards M, Huang Y, Bilate AM, Araujo LP, Tanoue T, Atarashi K, Ladinsky MS, Reiner SL, Wang HH, et al. Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome. Cell. 2022;18519:3501-3519.e3520. https:\/\/doi.org\/10.1016\/j.cell.2022.08.005.","journal-title":"Cell"},{"key":"1121_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"1393","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;1393:485\u201398. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033.","journal-title":"Cell"},{"key":"1121_CR49","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.239699","author":"MP McNamara","year":"2021","unstructured":"McNamara MP, Singleton JM, Cadney MD, Ruegger PM, Borneman J, Garland T. Early-life effects of juvenile Western diet and exercise on adult gut microbiome composition in mice. J Exp Biol. 2021. https:\/\/doi.org\/10.1242\/jeb.239699.","journal-title":"J Exp Biol"},{"key":"1121_CR50","doi-asserted-by":"publisher","first-page":"e0148421","DOI":"10.1128\/msystems.01484-21","volume":"72","author":"P P\u00e9rez Escriva","year":"2022","unstructured":"P\u00e9rez Escriva P, Fuhrer T, Sauer U. Distinct N and C cross-feeding networks in a synthetic mouse gut consortium. mSystems. 2022;72:e0148421. https:\/\/doi.org\/10.1128\/msystems.01484-21.","journal-title":"mSystems."},{"key":"1121_CR51","doi-asserted-by":"publisher","first-page":"23422","DOI":"10.1021\/jacs.3c09734","volume":"14543","author":"S Bang","year":"2023","unstructured":"Bang S, Shin YH, Ma X, Park SM, Graham DB, Xavier RJ, Clardy J. A cardiolipin from muribaculum intestinale induces antigen-specific cytokine responses. J Am Chem Soc. 2023;14543:23422\u20136. https:\/\/doi.org\/10.1021\/jacs.3c09734.","journal-title":"J Am Chem Soc"},{"key":"1121_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jare.2023.08.003","volume":"52","author":"X Zong","year":"2023","unstructured":"Zong X, Zhang H, Zhu L, Deehan EC, Fu J, Wang Y, Jin M. Auricularia auricula polysaccharides attenuate obesity in mice through gut commensal Papillibacter cinnamivorans. J Adv Res. 2023;52:203\u201318. https:\/\/doi.org\/10.1016\/j.jare.2023.08.003.","journal-title":"J Adv Res"},{"key":"1121_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-020-01595-w","volume":"181","author":"G Xie","year":"2020","unstructured":"Xie G, Wang X, Wei R, Wang J, Zhao A, Chen T, Wang Y, Zhang H, Xiao Z, Liu X, et al. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med. 2020;181:144. https:\/\/doi.org\/10.1186\/s12916-020-01595-w.","journal-title":"BMC Med"},{"key":"1121_CR54","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.redox.2022.102426","volume":"55","author":"H Chen","year":"2022","unstructured":"Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R, Jiang L. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR\/SREBP-1\/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol. 2022;55:102426. https:\/\/doi.org\/10.1016\/j.redox.2022.102426.","journal-title":"Redox Biol"},{"key":"1121_CR55","doi-asserted-by":"publisher","first-page":"122211","DOI":"10.1016\/j.envpol.2023.122211","volume":"334","author":"W He","year":"2023","unstructured":"He W, Gao Z, Liu S, Tan L, Wu Y, Liu J, Zheng Z, Fan W, Luo Y, Chen Z, et al. G protein-coupled estrogen receptor activation by bisphenol-A disrupts lipid metabolism and induces ferroptosis in the liver. Environ Pollut. 2023;334:122211. https:\/\/doi.org\/10.1016\/j.envpol.2023.122211.","journal-title":"Environ Pollut"},{"key":"1121_CR56","doi-asserted-by":"publisher","first-page":"102570","DOI":"10.1016\/j.redox.2022.102570","volume":"59","author":"P Liu","year":"2023","unstructured":"Liu P, Anandhan A, Chen J, Shakya A, Dodson M, Ooi A, Chapman E, White E, Garcia JG, Zhang DD. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Redox Biol. 2023;59:102570. https:\/\/doi.org\/10.1016\/j.redox.2022.102570.","journal-title":"Redox Biol"},{"key":"1121_CR57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"274","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;274:436\u201347. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.011.","journal-title":"Cell Chem Biol"},{"key":"1121_CR58","doi-asserted-by":"publisher","first-page":"42887","DOI":"10.1021\/acsami.2c10506","volume":"1438","author":"X Cai","year":"2022","unstructured":"Cai X, Hua S, Deng J, Du Z, Zhang D, Liu Z, Khan NU, Zhou M, Chen Z. Astaxanthin activated the Nrf2\/HO-1 pathway to enhance autophagy and inhibit ferroptosis, ameliorating acetaminophen-induced liver injury. ACS Appl Mater Interfaces. 2022;1438:42887\u2013903. https:\/\/doi.org\/10.1021\/acsami.2c10506.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1121_CR59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","volume":"125","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, Tang N. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis. Cell Death Dis. 2021;125:426. https:\/\/doi.org\/10.1038\/s41419-021-03718-4.","journal-title":"Cell Death Dis"},{"key":"1121_CR60","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/cas.15531","volume":"11311","author":"C Zeng","year":"2022","unstructured":"Zeng C, Lin J, Zhang K, Ou H, Shen K, Liu Q, Wei Z, Dong X, Zeng X, Zeng L, et al. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53\/SLC7A11\/GPX4 signaling. Cancer Sci. 2022;11311:3766\u201375. https:\/\/doi.org\/10.1111\/cas.15531.","journal-title":"Cancer Sci"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01121-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T09:27:15Z","timestamp":1766741235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01121-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01121-1","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The first author affiliation has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures received approval from the Animal Experimentation Ethics Committee of Fujian University of Traditional Chinese Medicine (Approval No.: FJTCM IACUC20221151).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}